Related Experiment Video
Updated: May 15, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
Mutation-Driven Remodeling of the LRRK2 Kinase Free-Energy Landscape and Its Consequences for Conformational
Rajesh Ghosh1, Kousik K Bhanja1, Niladri Patra1
1Department of chemistry & Chemical Biology, Indian Institute of Technology (ISM) Dhanbad, Dhanbad, Jharkhand 826004, India.
Abstract:
Parkinson's disease (PD), the second most common age-related neurodegenerative disorder worldwide, is associated with mutations in several genes, one of which is LRRK2 (leucine-rich repeat kinase 2). Despite cryo-EM structures elucidating the active and inactive architectures of the wild type (WT), the regulatory mechanisms and intermediate conformational states (INTs) that facilitate the transition between these forms, as well as the distinctions in the G2019S mutant, remain unclear. Here, we elucidated how mutations reshape the conformational dynamics through molecular dynamics simulations, highlighting the salt bridge contributions of the E1920-R2026 and K1906-D2017 residue pairs and fluctuations of the activation loop (A-loop) lid in stabilizing specific states. Furthermore, the reconstructed two-dimensional Well-Tempered Metadynamics (2D WT-MetaD) free-energy landscape along A-loop and K1906-E1920 coordinates revealed two distinct activation/inactivation pathways. Interestingly, the inactivation pathway in WT revealed a metastable "semi-open" state, while the G2019S mutation favored activation by decreasing the inactive-to-active energy barrier; however, once the active state was formed, it became comparatively stable and required more energy for the active-to-inactive transition than the WT. Thus, the G2019S mutation facilitated activation and remained in its active form, providing a mechanistic basis for its uncontrolled kinase hyperactivity. To reinforce the MetaD-derived stability of the G2019S active conformation over WT, we assessed the binding of the type-I inhibitor LRRK2-IN-1 for active state conformational rearrangements in the ligand-bound state. The absolute binding free-energy consistently showed that the ligand preferentially stabilizes the mutant active state, highlighting its binding affinity and modestly increased inhibitor potency, relative to WT. Finally, two-dimensional Umbrella Sampling (2D-US) showed apo-state transitions arising from DYGI (D2017-Y2018-G2019-I2020) rearrangements and αC-helix coupling via COM distances of K1906-E1920 and E1920-R2026 residue pairs. The results revealed that the mutant (G2019S) follows two routes with four INTs.
Insights
Mutations in LRRK2 (leucine-rich repeat kinase 2) are linked to Parkinson's disease. This study reveals how the G2019S mutation stabilizes the active kinase form, offering insights into disease mechanisms and drug development.
Area of Science:
- Biochemistry and Molecular Biology
- Neurodegenerative Diseases
- Structural Biology
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder linked to LRRK2 gene mutations.
- While wild-type (WT) LRRK2 structures are known, the transition states and mutant dynamics remain unclear.
- Understanding these dynamics is crucial for elucidating PD pathogenesis and developing targeted therapies.
Purpose of the Study:
- To elucidate how LRRK2 mutations, specifically G2019S, alter conformational dynamics.
- To identify intermediate conformational states (INTs) in LRRK2 activation and inactivation pathways.
- To investigate the impact of the G2019S mutation on kinase activity and inhibitor binding.
Main Methods:
- Molecular dynamics (MD) simulations to analyze conformational changes.
- Two-dimensional Well-Tempered Metadynamics (2D WT-MetaD) to map free-energy landscapes.
- Assessment of type-I inhibitor LRRK2-IN-1 binding affinity using absolute binding free-energy calculations.
- Two-dimensional Umbrella Sampling (2D-US) to study apo-state transitions.
Main Results:
- The G2019S mutation lowers the energy barrier for LRRK2 activation, favoring a hyperactive state.
- The mutant active state is more stable than WT, requiring more energy to transition back to inactivation.
- The type-I inhibitor LRRK2-IN-1 preferentially stabilizes the G2019S mutant active conformation.
- Specific salt bridges and activation loop dynamics were identified as key regulators of LRRK2 states.
Conclusions:
- The G2019S mutation facilitates sustained LRRK2 activation, explaining its kinase hyperactivity in PD.
- This study provides a mechanistic basis for the G2019S mutation's role in Parkinson's disease.
- Findings support the development of inhibitors that target the stabilized active conformation of mutant LRRK2.
Related Concept Videos
Cooperative Allosteric Transitions
Regulation of the Unfolded Protein Response
Ligand Binding and Linkage
Receptor Tyrosine Kinases
Allosteric Regulation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

